OSIR - Osiris Therapeutics Inc.
Previous close
18.99
18.990 100.000%
Share volume: 0
Last Updated: Tue 16 Apr 2019 10:00:00 PM CEST
Pharmaceuticals: Other:
0%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
59%
Profitability
89%
Dept financing
11%
Liquidity
28%
Performance
48%
Sector
Health Technology
Industry
Pharmaceuticals: Other
Long-term ratios 31-Dec-2014 - 31-Dec-2018
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
11.04%
Return on assets
2.21%
Return on sales
3.35%
Return on invested capital
56.9%
Total debt ratio
42.75%
Debt ratio change over timeo
-3.17%
Current Ratio
2.35%
Quick Ratio
2.01%
Cash Position Ratio
0.5%
Short-term ratios 31-Dec-2017 - 31-Dec-2018
The data are presented for the financials results of the quarters of the last year.
Return on equity
12.65%
Return on assets
2.85%
Return on sales
6.77%
Return on invested capital
72.71%
Total debt ratio
41.68%
Debt ratio change over timeo
-3.17%
Current Ratio
2.42%
Quick Ratio
2.08%
Cash Position Ratio
0.6%
Last quarter ratios 31-Dec-2018
The data are presented for the financials results of the last quarter.
Return on equity
41.42%
Return on assets
6.14%
Return on sales
15.26%
Return on invested capital
305.07%
Total debt ratio
22.63%
Debt ratio change over time
-2.69%
Current Ratio
3.41%
Quick Ratio
2.94%
Cash Position Ratio
0.79%
Performance ratios (change over 4 years) 31-Dec-2014 - 31-Dec-2018
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-161.76%
Return on assets
-107.33%
Return on sales
-116.55%
Return on invested capital
-684.94%
Total debt ratio
-317.33%
Debt ratio change over time
-3.17%
Current Ratio
-14.68%
Quick Ratio
-12.81%
Cash Position Ratio
-3.3%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | OSIR | MYOK | MDCO | ARQL |
|---|---|---|---|---|
| Return on equity | 11.04% | -5.27% | -112.12% | -30.68% |
| Return on assets | 2.21% | -4.64% | -6.57% | -12.29% |
| Return on sales | 3.35% | 0% | -592.81% | 0% |
| Return on invested capital | 56.9% | -112.29% | -44.35% | 69.34% |
| Profitability | 96% | 0% | 0% | 25% |
| Total debt ratio | 42.75% | 17.45% | 84.82% | 41.25% |
| Debt ratio change over time | -3.17% | -0.96% | -7.23% | -0.55% |
| Dept financing | 13% | 5% | 25% | 37% |
| Current Ratio | 2.42% | 7.62% | 3.15% | 7.07% |
| Quick Ratio | 2.08% | 0% | 3.13% | 0% |
| Cash Position Ratio | 0.6% | 6.34% | 2.37% | 1.52% |
| Liquididy | 32% | 50% | 43% | 30% |
| Short-term ratios | OSIR | MYOK | MDCO | ARQL |
|---|---|---|---|---|
| Return on equity | 12.65% | -5.34% | -15.43% | -8.38% |
| Return on assets | 2.85% | -5.01% | -5.39% | -3.19% |
| Return on sales | 6.77% | 0% | -727.71% | 0% |
| Return on invested capital | 72.71% | 157.52% | -15.37% | 42.7% |
| Profitability | 87% | 25% | 0% | 7% |
| Total debt ratio | 41.68% | 12.2% | 98.94% | 38.3% |
| Debt ratio change over time | -3.17% | -0.85% | -6.5% | -0.7% |
| Dept financing | 11% | 3% | 25% | 35% |
| Current Ratio | 2.42% | 7.62% | 3.15% | 7.07% |
| Quick Ratio | 2.08% | 0% | 3.13% | 0% |
| Cash Position Ratio | 0.6% | 6.34% | 2.37% | 1.52% |
| Liquididy | 27% | 50% | 45% | 29% |